- 专利标题： TREATMENT OF FABRY DISEASE IN ERT-NAIVE AND ERT-EXPERIENCED PATIENTS
-
申请号： EP24168026.3申请日： 2017-07-19
-
公开(公告)号： EP4389213A2公开(公告)日： 2024-06-26
- 发明人: Castelli, Jeff
- 申请人： Amicus Therapeutics, Inc.
- 申请人地址： US Philadelphia, PA 19104 3675 Market Street
- 专利权人： Amicus Therapeutics, Inc.
- 当前专利权人： Amicus Therapeutics, Inc.
- 当前专利权人地址： US Philadelphia, PA 19104 3675 Market Street
- 代理机构： Hoffmann Eitle
- 优先权： US 1615213920 2016.07.19
- 分案原申请号： 17745612.6 2017.07.19
- 主分类号： A61P13/12
- IPC分类号： A61P13/12
摘要：
Provided are dosing regimens for the treatment of Fabry disease in a patient. Certain methods relate to the treatment of ERT-experienced or ERT-naïve Fabry patients. Certain methods comprise administering to the patient about 123 mg free base equivalent of migalastat for improving left ventricular mass and/or improving podocyte globotriaosylceramide.
公开/授权文献
信息查询
